• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨基葡萄糖复合物对下背痛影响的开放标签、随机、对照试验性研究

Open-label, randomized, controlled pilot study of the effects of a glucosamine complex on Low back pain.

作者信息

Tant Laure, Gillard Bruno, Appelboom Thierry

机构信息

Division of Rheumatology and Physical Medicine, Erasme University Hospital, Brussels, Belgium.

出版信息

Curr Ther Res Clin Exp. 2005 Nov;66(6):511-21. doi: 10.1016/j.curtheres.2005.12.009.

DOI:10.1016/j.curtheres.2005.12.009
PMID:24678073
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC3965983/
Abstract

BACKGROUND

A series of studies has suggested some efficacy of glucosamine in arthrosis of the knee, but virtually no documentation exists regarding its effects on low back pain.

OBJECTIVES

The primary objective of this study was to examine whether a 12-week course of a glucosamine complex (GC) could benefit patients having low back pain despite a course of noninvasive physical therapy. In addition, we sought to delineate the subgroup of responders.

METHODS

This open-label, randomized, controlled study was conducted at the Division of Rheumatology and Physical Medicine, Erasme University Hospital, Brussels, Belgium. Male and female outpatients aged 40 to 80 years with low back pain (duration, ≥ 12 weeks; pain score on 10-cm visual analog scale [VAS] [0 = none to 10 = worst imaginable], ≥3 cm) despite noninvasive physical therapy (massage, stretching, heat application, and analgesics for ≥4 weeks) were included. Patients were randomly assigned to receive, in addition to conventional treatment (CT) (physical therapy plus analgesics/antiinflammatories), a GC (enriched with sulfonyl methane, silicon, and a botanical extract of Ribes nigrum) or CT alone (control) for 12 weeks. Pain at rest and on movement (effort) and early morning lumbar stiffness were measured every 4 weeks using the VAS. The primary end point was improvement in VAS score for pain at rest at 12 weeks. Two validated questionnaires were used to assess improvements in quality of life (QOL) (Oswestry Disability Questionnaire [ODQ] [10 items; scale: 0 = no disability to 60 = maximal disability] and Roland-Morris Disability Questionnaire [RMDQ] [24 items; scale: 0 = no disability to 24 = severe disability]). Responders were defined as patients who positively assessed the efficacy of the GC. At each visit, patients were also asked about possible adverse events.

RESULTS

Of 36 enrolled patients, 32 completed the study (18 men, 14 women; mean [SE] age, 64 [2] years; 17 in the GC group and 15 in the control group). Four patients were lost to follow-up. At week 4, changes from baseline VAS scores for pain at rest and lumbar stiffness were significantly greater in the GC group compared with the control group (P < 0.001 and P = 0.011, respectively). At week 4, QOL was found to be improved, as measured using the ODQ, in the GC group compared with the control group (P = 0.028), but the between-group difference as measured using the RMDQ was not significant. The improvements from baseline on the questionnaires were sustained over the 12-week period in the GC group (all, P < 0.001). Gastrointestinal adverse effects were reported by 1 GC-treated patient and 1 patient in the control group, but neither patient withdrew from the study. Of the 17 GC-treated patients, 9 considered themselves responders, but the profile of a responder could not be delineated.

CONCLUSIONS

In this study in patients with low back pain, analgesic effect and improvement in QOL were found with the use of GC. GC was well tolerated.

摘要

背景

一系列研究表明氨基葡萄糖对膝关节骨关节炎有一定疗效,但几乎没有关于其对腰痛影响的文献记载。

目的

本研究的主要目的是检验为期12周的氨基葡萄糖复合物(GC)疗程是否能使尽管接受了无创物理治疗但仍患有腰痛的患者受益。此外,我们试图确定有反应的亚组。

方法

本开放标签、随机、对照研究在比利时布鲁塞尔伊拉斯谟大学医院风湿病与物理医学科进行。纳入年龄在40至80岁之间、尽管接受了无创物理治疗(按摩、拉伸、热敷和使用镇痛药≥4周)但仍患有腰痛(病程≥12周;在10厘米视觉模拟量表[VAS][0 = 无疼痛至10 = 难以想象的剧痛]上疼痛评分≥3厘米)的门诊男女患者。患者被随机分配,除接受常规治疗(CT)(物理治疗加镇痛药/抗炎药)外,一组接受GC(富含甲磺酰甲烷、硅和黑醋栗植物提取物),另一组仅接受CT(对照组),为期12周。每4周使用VAS测量静息和活动时(用力时)的疼痛以及清晨腰椎僵硬程度。主要终点是12周时静息疼痛的VAS评分改善情况。使用两份经过验证的问卷评估生活质量(QOL)的改善情况(奥斯威斯残疾问卷[ODQ][10项;评分范围:0 = 无残疾至60 = 最大残疾]和罗兰-莫里斯残疾问卷[RMDQ][24项;评分范围:0 = 无残疾至24 = 严重残疾])。有反应者定义为对GC疗效给予肯定评价的患者。每次就诊时,还询问患者是否有可能的不良事件。

结果

36名入组患者中,32名完成了研究(18名男性,14名女性;平均[标准差]年龄,64[2]岁;GC组17名,对照组15名)。4名患者失访。在第4周时,GC组静息疼痛和腰椎僵硬的VAS评分相对于基线的变化显著大于对照组(分别为P < 0.001和P = 0.011)。在第4周时,使用ODQ测量发现GC组的QOL相对于对照组有所改善(P = 0.028),但使用RMDQ测量的组间差异不显著。GC组在12周期间问卷相对于基线的改善情况持续存在(均为P < 0.001)。1名接受GC治疗的患者和1名对照组患者报告有胃肠道不良反应,但均未退出研究。在17名接受GC治疗的患者中,9名认为自己是有反应者,但无法确定有反应者的特征。

结论

在本针对腰痛患者的研究中,使用GC发现有镇痛作用且生活质量得到改善。GC耐受性良好。

相似文献

1
Open-label, randomized, controlled pilot study of the effects of a glucosamine complex on Low back pain.氨基葡萄糖复合物对下背痛影响的开放标签、随机、对照试验性研究
Curr Ther Res Clin Exp. 2005 Nov;66(6):511-21. doi: 10.1016/j.curtheres.2005.12.009.
2
Is immediate imaging important in managing low back pain?在处理下腰痛时,立即进行影像学检查重要吗?
J Athl Train. 2011 Jan-Feb;46(1):99-102. doi: 10.4085/1062-6050-46.1.99.
3
Clinical Efficacy of Neurotropin for Lumbar Spinal Stenosis with Low Back Pain.神经妥乐平治疗伴有腰痛的腰椎管狭窄症的临床疗效
Pain Ther. 2023 Apr;12(2):461-473. doi: 10.1007/s40122-022-00472-z. Epub 2023 Jan 16.
4
Effect of glucosamine on pain-related disability in patients with chronic low back pain and degenerative lumbar osteoarthritis: a randomized controlled trial.氨基葡萄糖对慢性腰痛和退行性腰椎骨关节炎患者疼痛相关残疾的影响:一项随机对照试验。
JAMA. 2010 Jul 7;304(1):45-52. doi: 10.1001/jama.2010.893.
5
Correlation of quality of life scores to clinical outcome of lumbar epidural steroids in chronic low back pain.慢性下腰痛患者生活质量评分与腰椎硬膜外类固醇治疗临床疗效的相关性
Anesth Essays Res. 2016 Sep-Dec;10(3):574-579. doi: 10.4103/0259-1162.183563.
6
Shiatsu for chronic lower back pain: Randomized controlled study.指压按摩治疗慢性下腰痛:随机对照研究。
Complement Ther Med. 2019 Aug;45:33-37. doi: 10.1016/j.ctim.2019.05.019. Epub 2019 May 16.
7
Effects of valdecoxib in the treatment of chronic low back pain: results of a randomized, placebo-controlled trial.伐地考昔治疗慢性下腰痛的效果:一项随机、安慰剂对照试验的结果。
Clin Ther. 2004 Aug;26(8):1249-60. doi: 10.1016/s0149-2918(04)80081-x.
8
The Effect of M-Health-Based Core Stability Exercise Combined with Self-Compassion Training for Patients with Nonspecific Chronic Low Back Pain: A Randomized Controlled Pilot Study.基于移动健康的核心稳定性训练联合自我同情训练对非特异性慢性下腰痛患者的影响:一项随机对照试验性研究
Pain Ther. 2022 Jun;11(2):511-528. doi: 10.1007/s40122-022-00358-0. Epub 2022 Feb 8.
9
Diazepam Is No Better Than Placebo When Added to Naproxen for Acute Low Back Pain.地西泮与萘普生联用治疗急性下腰痛时并不比安慰剂效果更好。
Ann Emerg Med. 2017 Aug;70(2):169-176.e1. doi: 10.1016/j.annemergmed.2016.10.002. Epub 2017 Feb 7.
10
The short-term effects of balneotherapy on pain, disability and fatigue in patients with chronic low back pain treated with physical therapy: A randomized controlled trial.水疗对接受物理治疗的慢性腰痛患者疼痛、残疾和疲劳的短期影响:一项随机对照试验。
Complement Ther Med. 2020 Nov;54:102550. doi: 10.1016/j.ctim.2020.102550. Epub 2020 Sep 4.

引用本文的文献

1
Methylsulfonylmethane: Applications and Safety of a Novel Dietary Supplement.甲基磺酰甲烷:一种新型膳食补充剂的应用与安全性
Nutrients. 2017 Mar 16;9(3):290. doi: 10.3390/nu9030290.
2
Herbal medicine for low-back pain.用于治疗腰痛的草药
Cochrane Database Syst Rev. 2014 Dec 23;2014(12):CD004504. doi: 10.1002/14651858.CD004504.pub4.
3
The use of glucosamine for chronic low back pain: a systematic review of randomised control trials.氨基葡萄糖治疗慢性下腰痛的系统评价:随机对照试验研究
BMJ Open. 2013 Jun 20;3(6):e001167. doi: 10.1136/bmjopen-2012-001167.

本文引用的文献

1
Osteoarthritis: an overview of the disease and its treatment strategies.骨关节炎:疾病概述及其治疗策略
Semin Arthritis Rheum. 2005 Aug;35(1 Suppl 1):1-10. doi: 10.1016/j.semarthrit.2005.01.013.
2
Glucosamine long-term treatment and the progression of knee osteoarthritis: systematic review of randomized controlled trials.氨基葡萄糖长期治疗与膝关节骨关节炎的进展:随机对照试验的系统评价
Ann Pharmacother. 2005 Jun;39(6):1080-7. doi: 10.1345/aph.1E576. Epub 2005 Apr 26.
3
Glucosamine effects in humans: a review of effects on glucose metabolism, side effects, safety considerations and efficacy.氨基葡萄糖对人体的影响:对葡萄糖代谢、副作用、安全考量及疗效的综述
Food Chem Toxicol. 2005 Feb;43(2):187-201. doi: 10.1016/j.fct.2004.11.006.
4
A prodrug approach to COX-2 inhibitors with methylsulfone.一种含甲基砜的COX-2抑制剂的前药方法。
Bioorg Med Chem Lett. 2004 Apr 5;14(7):1757-60. doi: 10.1016/j.bmcl.2004.01.048.
5
Glucosamine sulfate reduces osteoarthritis progression in postmenopausal women with knee osteoarthritis: evidence from two 3-year studies.硫酸葡萄糖胺可减缓绝经后膝骨关节炎女性的骨关节炎进展:来自两项为期3年研究的证据。
Menopause. 2004 Mar-Apr;11(2):138-43. doi: 10.1097/01.gme.0000087983.28957.5d.
6
Effects of prodelphinidins isolated from Ribes nigrum on chondrocyte metabolism and COX activity.从黑醋栗中分离出的原花青素对软骨细胞代谢和COX活性的影响。
Naunyn Schmiedebergs Arch Pharmacol. 2002 Jun;365(6):434-41. doi: 10.1007/s00210-002-0553-y. Epub 2002 Apr 26.
7
Sulfur in human nutrition and applications in medicine.人体营养中的硫及其在医学中的应用。
Altern Med Rev. 2002 Feb;7(1):22-44.
8
Leaf lipids of Ribes nigrum: a plant containing 16:3, alpha-18:3, gamma-18:3 and 18:4 fatty acids.黑醋栗叶片脂质:一种含有16:3、α-18:3、γ-18:3和18:4脂肪酸的植物。
Biochem Soc Trans. 2000 Dec;28(6):583-6.
9
Nonsteroidal anti-inflammatory drugs for low back pain: a systematic review within the framework of the Cochrane Collaboration Back Review Group.非甾体抗炎药治疗腰痛:Cochrane协作网背部回顾小组框架内的系统评价
Spine (Phila Pa 1976). 2000 Oct 1;25(19):2501-13. doi: 10.1097/00007632-200010010-00013.
10
Effect of glucosamine hydrochloride in the treatment of pain of osteoarthritis of the knee.
J Rheumatol. 1999 Nov;26(11):2423-30.